Clomiphene in pharma franchise in Assam

Clomiphene in PCD pharma franchise in Kohima

Clomiphene in top pharma company in Navi Mumbai

Clomiphene in pcd pharma supplier in Belagavi

Clomiphene in phama franchise comoany in India
Clomiphene in phama distributor in Kochi

Home/Products /clomiphene-25mg-tablet

Clomihead 25 Tablet

Composition : Clomiphene (25mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹64/-

Clomihead 25 Tablet contains 25 mg of clomiphene, a selective estrogen receptor modulator (SERM) commonly used to address specific infertility issues in women. By promoting the release of key hormones responsible for ovulation, Clomihead 25 helps in managing ovulatory disorders that can prevent conception. Clomiphene works on the hypothalamus to boost the production of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which are essential for ovarian follicle development and egg release.

Clomihead 25 is a lower-dose option, often used in initial treatments or for patients who require careful hormonal adjustments. The tablet aids in creating favorable conditions for ovulation, particularly for women with polycystic ovary syndrome (PCOS) or irregular menstrual cycles. As a first-line treatment, it offers a targeted, lower-dose approach that can enhance natural conception chances under the guidance of a healthcare provider.

Read More

About the Product

Clomihead 25 Tablet contains 25 mg of clomiphene, a selective estrogen receptor modulator (SERM) commonly used to address specific infertility issues in women. By promoting the release of key hormones responsible for ovulation, Clomihead 25 helps in managing ovulatory disorders that can prevent conception. Clomiphene works on the hypothalamus to boost the production of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which are essential for ovarian follicle development and egg release.

Clomihead 25 is a lower-dose option, often used in initial treatments or for patients who require careful hormonal adjustments. The tablet aids in creating favorable conditions for ovulation, particularly for women with polycystic ovary syndrome (PCOS) or irregular menstrual cycles. As a first-line treatment, it offers a targeted, lower-dose approach that can enhance natural conception chances under the guidance of a healthcare provider.

Common side effects can include hot flashes, bloating, headache, nausea, and occasional visual disturbances. Rare side effects may include ovarian hyperstimulation, requiring medical evaluation. Proper storage conditions ensure the efficacy and safety of Clomihead 25 Tablet.

Clomihead 25 Tablet is indicated for treating ovulatory dysfunction in women aiming to conceive, especially in cases such as PCOS or unexplained infertility. Clomihead 25 is generally well-tolerated, though some side effects may occur.

Clomihead 25 Tablet should only be taken under the guidance of a qualified healthcare provider. Timing and dosing are crucial for its success, so a thorough medical history and evaluation are recommended before beginning treatment, especially for patients with liver disorders or hormone-sensitive conditions. Clomihead 25 Tablet offers a careful, effective approach to enhancing fertility, providing a balanced dosage option for women seeking assistance in achieving pregnancy. Its proven track record, combined with ease of administration, makes it a trusted choice in reproductive health.

Store Clomihead 25 Tablet at room temperature, ideally below 25°C (77°F), in a cool, dry place, away from direct sunlight and moisture. Keep the product out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation